
Rep. Glenn Grothman @RepGrothman
Biosimilars are effective and less costly versions of biologic drugs, like insulin. I asked these drug company CEOs if they agree that more biosimilar products should be on the market. @BiosimCenter https://t.co/G7c6fGvATZ — PolitiTweet.org